Krystal Biotech, Inc. (KRYS) ownership: Top institutional holder: FMR LLC ($1.13B). Insider activity: Net Seller (0 buys, 20 sells). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 4373987.00 | $1.13B | 2026-03-31 |
| BlackRock, Inc. | 3940456.00 | $1.02B | 2026-03-31 |
| Avoro Capital Advisors LLC | 2888888.00 | $746.26M | 2026-03-31 |
| VANGUARD GROUP INC | 2778845.00 | $685.10M | 2025-12-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1456727.00 | $376.30M | 2026-03-31 |
| STATE STREET CORP | 1314434.00 | $339.54M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1165324.00 | $301.03M | 2026-03-31 |
| Soleus Capital Management, L.P. | 1153087.00 | $297.87M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-26 | |
| Sell | null | 2026-03-04 | |
| Sell | null | 2026-03-04 | |
| Sell | null | 2026-03-04 | |
| Sell | null | 2026-03-04 | |
| Sell | null | 2026-03-04 | |
| Sell | null | 2026-03-04 | |
| Sell | null | 2026-03-04 |
Back to KRYS overview · KRYS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.